QIAGEN Introduces Novel Technology and Product Line That Significantly Accelerates PCR Reactions
biz.yahoo.com
Tuesday October 24, 7:36 am ET
New Fast Cycling PCR Technology Increases Speed of the Standard Biology Technique by Factor of Four
VENLO, Netherlands, Oct. 24, 2006 (PRIMEZONE) -- QIAGEN, the world's leading provider of products for preanalytical sample preparation and molecular diagnostics, today launched its new QIAGEN Fast Cycling PCR product line, which substantially accelerates and streamlines the polymerase chain reaction (PCR). PCR is a standard technique for replicating genetic material that is used in genetic research and analysis in almost all biology laboratories worldwide. The use of the newly launched QIAGEN Fast Cycling PCR kit enables users to save up to 75% of the time previously required for the technique. This significant increase in speed is achieved without compromising the quality of results.
The kit is compatible with all makes and types of PCR machines (so called thermal cyclers) and with current PCR assays. Unlike other available PCR reagents, the use of the QIAGEN Fast Cycling PCR Kit does not require laborious optimization (e.g. redesigning primers or PCR protocols). The kit therefore enables significant time and cost savings without the need for new equipment and sets new standards for speed and accuracy in PCR.
The availability of the new QIAGEN Fast Cycling PCR Kit for general PCR applications and for amplification of complex DNA templates extends QIAGEN's wide portfolio of assay technology solutions for research and diagnostics and satisfies the increasing demand for greater speed in PCR.
In comparison with other commercially available PCR reagent kits, the new method dramatically reduces cycling times by 1 hour down to under 20 minutes. The key to this new dimension of performance in PCR technology is an innovative PCR additive system.
``This novel, proprietary technology opens a new dimension of potentials for PCR. The innovative new QIAGEN Fast Cycling PCR product line launched today offers PCR users the opportunity to increase PCR throughput by a factor of four, without triggering investments in new laboratory equipment and without compromising the quality of their results,'' said Dr. Ulla Deutsch, Senior Global Product Manager Amplification at QIAGEN.
QIAGEN's Fast Cycling PCR product line is for research use only. It has not been cleared or approved by authorities including the United States Food and Drug Administration or any other regulatory agency in the United States, or under the European IVD Directive, for human diagnostic or other clinical use, and is not intended and should not be used for human diagnostic or any other clinical purposes. |
